YEM Search

搜索结果

GABRA5

靶点ID:TCMBANKGE004917

靶点别名:EIEE79

靶点描述:gamma-aminobutyric acid type A receptor subunit alpha5

染色体:15

染色体位置:15q12

靶点类型:protein-coding

HERB_ID:-

HGNC_Link:4079

OMIM_Link:137142

Ensembl_Link:ENSG00000186297

靶点对应的植物

ID	拉丁名	药名	药用植物名	功能与主治	来源	药用部位	使用民族

靶点对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN005072	Secobarbital		C12H18N2O3	238.28 g/mol	CCCC(C)C1(C(=O)NC(=O)NC1=O)CC=C
TCMBANKIN057964	Immune globulin from;gaba;γ-aminobutyricacid;aminobutyric acid	γ-aminobutyric acid	C4H9NO2		C(CC(=O)O)CN
TCMBANKIN058229	daidzein	Daidzei; 486-66-8; AIDS-059333; ST057515; KBio2_005871; CCRIS 7600; 7-Hydroxy-3-(4-hydroxy- phenyl)- chromone; SPBio_000205; AIDS059333; 4′,7-Dihydroxy- iso- flavone; nchembio.2007.28-comp31; KBio2_003303; Spectrum3_000191; Isoflavone, 4',7-dihydroxy- (8CI); Oprea1_182317; 7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one; Spectrum5_000857; NCGC00025156-01; BiomolKI_000060; S00273; NCGC00015365-01; KBio1_001023; BiomolKI2_000066; KBioSS_000735; Daidzeol; SMP1_000089; 7,4'-Dihydroxyisoflavone; 7-Hydroxy-3-(4-hydroxyphenyl)-4-benzopyrone; C10208; SPECTRUM200789; nchembio.76-comp16; BSPBio_001741; NCGC00025156-09; Daidzein (6CI); 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-hydroxyphenyl)-; BRN 0231523; 5-18-04-00089 (Beilstein Handbook Reference); Daidzein; Daidzein (4',7-Dihydroxyisoflavone); KBioGR_002432; NINDS_001023; KBio2_000735; ACon1_000543; NCGC00025156-07; ZINC00047551; daidzein ; NCGC00025156-02; Lopac-D-7802; Tocris-1417; 7-hydroxy-3-(4-hydroxyphenyl)chromone; ACon0_001477; 7-Hydroxy-3-(4-hydroxy-phenyl)-chromone; KBio3_001241; DivK1c_001023; Spectrum4_001964; K 251b; UPCMLD-DP052:001; IDI1_001023; MEGxm0_000123; Lopac0_000412; D7802_SIGMA; Spectrum2_000053; EINECS 207-635-4; Spectrum_000255; 4′,7-Dihydroxyisoflavone; NCGC00025156-05; 4',7-Dihydroxy-iso-flavone; NCGC00025156-04; 7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one; 7-Hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 7-hydroxy-3-(4-hydroxyphenyl)-4-chromenone; 7-Hydroxy-3-(4-hydroxy- phenyl)-4H-1-benzo- pyran-4-one; EU-0100412; CHEBI:28197; SDCCGMLS-0066422.P001; 4',7-Dihydroxyisoflavone; Oprea1_305345	C15H10O4	254.24	C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3)O)O

靶点对应的疾病

疾病ID	疾病名	MeSH名	HPO名	UMLS名	疾病类型

TCMBANKDI003117		Nervous System Diseases	-	Disease or Syndrome	disease
TCMBANKDI003411		-	-	Disease or Syndrome	disease
TCMBANKDI004331		Pathological Conditions, Signs and Symptoms; Nervous System Diseases	-	Disease or Syndrome	phenotype
TCMBANKDI005272		Pathological Conditions, Signs and Symptoms; Nervous System Diseases	-	Sign or Symptom	phenotype
TCMBANKDI007012		Pathological Conditions, Signs and Symptoms; Nervous System Diseases	-	Pathologic Function	phenotype
TCMBANKDI009278		Mental Disorders	-	Mental or Behavioral Dysfunction	group
TCMBANKDI010792		Mental Disorders	-	Mental or Behavioral Dysfunction	disease
TCMBANKDI014132		Pathological Conditions, Signs and Symptoms; Nervous System Diseases	Abnormality of the nervous system	Disease or Syndrome	disease
TCMBANKDI014716		Nervous System Diseases	-	Disease or Syndrome	disease
TCMBANKDI015485		Mental Disorders	Abnormality of the nervous system	Mental or Behavioral Dysfunction	disease
TCMBANKDI016700		Mental Disorders	-	Mental or Behavioral Dysfunction	disease
TCMBANKDI017008		Pathological Conditions, Signs and Symptoms; Nervous System Diseases	Abnormality of the nervous system	Disease or Syndrome	disease
TCMBANKDI023464		Nervous System Diseases	Abnormality of the nervous system	Disease or Syndrome	disease
TCMBANKDI024057		Pathological Conditions, Signs and Symptoms; Nervous System Diseases	-	Disease or Syndrome	phenotype
TCMBANKDI024134		Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms	-	Mental or Behavioral Dysfunction	phenotype
TCMBANKDI025632		Mental Disorders	-	Mental or Behavioral Dysfunction	disease
TCMBANKDI031570		-	Abnormality of the nervous system	Mental or Behavioral Dysfunction	disease
TCMBANKDI031754		Pathological Conditions, Signs and Symptoms; Nervous System Diseases	-	Pathologic Function	phenotype